EuroImmun Launches SARS-CoV-2 NeutraLISA Assay
The EuroImmun SARS-CoV-2 NeutraLISA assay is a surrogate neutralization test intended for the detection of neutralizing antibodies against SARS-CoV-2, the pathogen causing covid-19.
Read MorePosted by Melanie Hamilton-Basich | Apr 27, 2021 | Covid 19 |
The EuroImmun SARS-CoV-2 NeutraLISA assay is a surrogate neutralization test intended for the detection of neutralizing antibodies against SARS-CoV-2, the pathogen causing covid-19.
Read MorePosted by Melanie Hamilton-Basich | Apr 27, 2021 | Covid 19, Research |
Akershus University Hospital and Bio-Me are collaborating on a study of the long-term effects of covid-19 in adolescents and young adults, investigating the involvement of the microbiome.
Read MorePosted by Melanie Hamilton-Basich | Apr 27, 2021 | Covid 19 |
The Edison Awards committee recognized Ortho’s Vitros Anti-SARS-CoV-2 Total and IgG Antibody Tests and Vitros SARS-CoV-2 Antigen Test in the innovation subcategory for accelerated testing solutions.
Read MorePosted by Melanie Hamilton-Basich | Apr 26, 2021 | Covid 19 |
NIH announced three new contracts and one new award to an existing contract for scale-up and manufacturing of novel covid-19 testing technologies.
Read MorePosted by Melanie Hamilton-Basich | Apr 26, 2021 | Covid 19 |
New findings from Rockefeller University suggest that so-called breakthrough cases may be driven by rapid evolution of the virus, and that ongoing covid-19 testing of immunized individuals will be important to help mitigate future outbreaks.
Read More